These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12470258)

  • 1. Integration of NMR and high-throughput screening.
    Hajduk PJ; Burns DJ
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):613-21. PubMed ID: 12470258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of SHAPES screening in drug discovery.
    Lepre CA; Peng J; Fejzo J; Abdul-Manan N; Pocas J; Jacobs M; Xie X; Moore JM
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):583-90. PubMed ID: 12470255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR screening in fragment-based drug design: a practical guide.
    Kim HY; Wyss DF
    Methods Mol Biol; 2015; 1263():197-208. PubMed ID: 25618347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High impact technologies for natural products screening.
    Koehn FE
    Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR-based approaches for lead discovery.
    Wyss DF; McCoy MA; Senior MM
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):630-47. PubMed ID: 12197321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of NMR in lead optimization: fragment-based approaches.
    Huth JR; Sun C
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):631-43. PubMed ID: 12470260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR and in silico screening.
    Rüdisser S; Jahnke W
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):591-603. PubMed ID: 12470256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in high-throughput high-performance liquid chromatography and "purification-friendly" combinatorial library design strategies.
    Schefzick S
    Adv Chromatogr; 2007; 45():197-213. PubMed ID: 17626560
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of high throughput technology for the screening of natural products.
    Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
    Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability.
    Dalvit C; Fogliatto G; Stewart A; Veronesi M; Stockman B
    J Biomol NMR; 2001 Dec; 21(4):349-59. PubMed ID: 11824754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
    Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
    Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of NMR to structure-based drug design in structural genomics.
    Powers R
    J Struct Funct Genomics; 2002; 2(2):113-23. PubMed ID: 12836668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective progression of nuclear magnetic resonance-detected fragment hits.
    Eaton HL; Wyss DF
    Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.